NPPES file of Aug 9, 2026

Lara Theobald, MD

Hematology & Oncology Physician · Oklahoma City, OK

Lara Theobald, MD is a hematology & oncology physician with a practice address in Oklahoma City, Oklahoma, and NPI 1376690271, issued on Jan 4, 2007. Check the license (Oklahoma 22010, as entered in NPPES) on the Oklahoma Board of Medical Licensure and Supervision; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1376690271
Name
Lara Theobald
Credential
MD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
22010 OK
Self-reported in NPPES; status is on the state search
Practice location
5915 W Memorial RD, Oklahoma City, OK 73142
Phone
(405) 773-6400
Enumerated
Jan 4, 2007
Record last updated
Jun 27, 2017 (not updated in 9 years: call before relying on the address or phone)
Fax
(405) 621-5441
Medicare enrollment
Enrolled (PECOS I20100329000472); accepts Medicare assignment
Medical or professional school
University Of Oklahoma College Of Medicine, 2000
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 5915 W Memorial RD

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Serena Anderson, M.D.Family Medicine Physician1659683589
  2. Allyson Black, MDDermatology Physician1760703730
  3. Charlotte Coyner-Gregory, M.D.Family Medicine Physician1205066958
  4. Jeffrey Cruzan, M.D.Family Medicine Physician1184661977
  5. Loahn Gallegos, MDFamily Medicine Physician1811257983
  6. Robert Hooper, DPH.Pharmacist1639499379

Verify Lara Theobald in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersOklahoma Board of Medical Licensure and Supervision
    Search for license 22010
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Oklahoma license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

76% more Medicare Part D claims than the average hematology & oncology physician in 2024

1,543 Medicare Part D claims for 324 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 13% of claims. 105 claims were for opioids.

  1. Lara Theobald1,543
  2. Specialty average877

Most prescribed

  1. Anastrozole416 claims
  2. Letrozole137 claims
  3. Ibrance53 claims
  4. Gabapentin47 claims
  5. Veozah46 claims
  6. Exemestane44 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 77.7 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score82.5
  2. Costout of 100 · 30%43.1
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $1,163.66

12 payments; by number, the most common kind was long term medical supply or device loan; the largest payer was Novartis Pharmaceuticals Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Lara Theobald$1,163.66
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Integris Ambulatory Care CorporationOklahoma City, OK

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Lara Theobald among 128 hematology & oncology physician records in Oklahoma

Lara Theobald, MD is one of 128 hematology & oncology physician records with a practice address in Oklahoma. 90% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 48% of them.

  • NPI issued2007 · 48% of these records are older, 40% newer
  • In a Medicare fileYes · 90% of these records are
  • In the CMS Doctors and Clinicians fileYes · 76% of these records are
  • Graduated2000 · median 2004 among the 97 with a school on file
  • Record last updated2017 · 65% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Oklahoma practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Hematology & Oncology Physician providers in Oklahoma

There are 128 hematology & oncology physician records in Oklahoma.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. Janae Clapp, M.D.Oklahoma City, OK 731421932151560
  2. Brian Geister, M.D.Oklahoma City, OK 731421568400471
  3. Romeo Mandanas, M.D.Oklahoma City, OK 731421114974466
  4. Johnny McMinn, M.D.Oklahoma City, OK 731421124069364
  5. Agnel Raparthi, M.D.,Oklahoma City, OK 731421235397654
  6. Irim Yasin, M.D.Oklahoma City, OK 731421699921734
  7. Jess Armor, M.D.Oklahoma City, OK 731341922059666
  8. Abby Bova, MDOklahoma City, OK 731201013058452

Common questions

What is Lara Theobald, MD's NPI number?

Lara Theobald, MD's National Provider Identifier (NPI) is 1376690271, issued on Jan 4, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Lara Theobald, MD located?

The NPPES record lists a practice address at 5915 W Memorial RD, Oklahoma City, OK, 73142. Phone: (405) 773-6400. Providers update this record themselves, so call before visiting.

How can I verify Lara Theobald, MD's license?

NPPES lists Oklahoma license number 22010, as entered by the provider. Search the Oklahoma Board of Medical Licensure and Supervision at https://www.okmedicalboard.org/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Lara Theobald, MD prescribe under Medicare Part D?

In 2024, Lara Theobald, MD had 1,543 Medicare Part D claims for 324 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

What is Lara Theobald, MD's MIPS final score?

The 2023 MIPS final score is 77.7 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.